Does LORLATINIB Cause Dyspnoea? 223 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 223 reports of Dyspnoea have been filed in association with LORLATINIB (Lorbrena). This represents 4.1% of all adverse event reports for LORLATINIB.
223
Reports of Dyspnoea with LORLATINIB
4.1%
of all LORLATINIB reports
49
Deaths
113
Hospitalizations
How Dangerous Is Dyspnoea From LORLATINIB?
Of the 223 reports, 49 (22.0%) resulted in death, 113 (50.7%) required hospitalization, and 9 (4.0%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORLATINIB. However, 223 reports have been filed with the FAERS database.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Off label use (394)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Oedema peripheral (198)
Oedema (195)
Fatigue (188)
Peripheral swelling (164)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which LORLATINIB Alternatives Have Lower Dyspnoea Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE